A. Ceesay

Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.

H. Larson, B. Kampmann, P. Johm, 2021, Vaccine.

The use of a speaking book® to enhance vaccine knowledge among caregivers in The Gambia: A study using qualitative and quantitative methods

S. Kochhar, B. Kampmann, P. Johm, 2021, BMJ Open.

Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa.

Maimuna Mendy, U. d’Alessandro, M. Thursz, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical utility of the 'Determine HBsAg' Point-of-Care Test for Diagnosis of Hepatitis B Surface Antigen in Africa

I. Chemin, M. Lemoine, D. Cohen, 2022, Expert review of molecular diagnostics.

Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries

I. Chemin, M. Lemoine, B. Testoni, 2022, Microorganisms.

Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa.

U. d’Alessandro, M. Thursz, I. Chemin, 2018, Journal of hepatology.

Hepatitis E virus infection and acute‐on‐chronic liver failure in West Africa: a case–control study from The Gambia

S. Taylor-Robinson, U. d’Alessandro, M. Thursz, 2016, Alimentary pharmacology & therapeutics.

Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa

M. Thursz, I. Chemin, I. Baldeh, 2022, Journal of global health.

Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study.

M. Thursz, I. Chemin, M. Lemoine, 2023, Lancet Global Health.

Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa

R. Njie, Y. Shimakawa, D. Cohen, 2020 .